These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 28719178)

  • 1. Therapeutic Role and Drug Delivery Potential of Neuroinflammation as a Target in Neurodegenerative Disorders.
    Singh A; Chokriwal A; Sharma MM; Jain D; Saxena J; Stephen BJ
    ACS Chem Neurosci; 2017 Aug; 8(8):1645-1655. PubMed ID: 28719178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanomedicine and its application in treatment of microglia-mediated neuroinflammation.
    Baby N; Patnala R; Ling EA; Dheen ST
    Curr Med Chem; 2014; 21(37):4215-26. PubMed ID: 25039775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Challenges and opportunities in CNS delivery of therapeutics for neurodegenerative diseases.
    Barchet TM; Amiji MM
    Expert Opin Drug Deliv; 2009 Mar; 6(3):211-25. PubMed ID: 19290842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biomaterials and glia: Progress on designs to modulate neuroinflammation.
    Tsui C; Koss K; Churchward MA; Todd KG
    Acta Biomater; 2019 Jan; 83():13-28. PubMed ID: 30414483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent Advances in Neuroinflammation Therapeutics: PPARs/LXR as Neuroinflammatory Modulators.
    Bastias-Candia S; Garrido A N; Zolezzi JM; Inestrosa NC
    Curr Pharm Des; 2016; 22(10):1312-23. PubMed ID: 26696410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent developments in the inhibitors of neuroinflammation and neurodegeneration: inflammatory oxidative enzymes as a drug target.
    Choi DK; Koppula S; Choi M; Suk K
    Expert Opin Ther Pat; 2010 Nov; 20(11):1531-46. PubMed ID: 20939683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of the blood brain barrier in neurodegenerative disorders and their treatment.
    Palmer AM
    J Alzheimers Dis; 2011; 24(4):643-56. PubMed ID: 21460432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current insights on lipid nanocarrier-assisted drug delivery in the treatment of neurodegenerative diseases.
    Teixeira MI; Lopes CM; Amaral MH; Costa PC
    Eur J Pharm Biopharm; 2020 Apr; 149():192-217. PubMed ID: 31982574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroinflammatory processes in cognitive disorders: Is there a role for flavonoids and n-3 polyunsaturated fatty acids in counteracting their detrimental effects?
    Vauzour D; Martinsen A; Layé S
    Neurochem Int; 2015 Oct; 89():63-74. PubMed ID: 26260547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resveratrol as a protective molecule for neuroinflammation: a review of mechanisms.
    Renaud J; Martinoli MG
    Curr Pharm Biotechnol; 2014; 15(4):318-29. PubMed ID: 24938890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroinflammation and Infection: Molecular Mechanisms Associated with Dysfunction of Neurovascular Unit.
    Tohidpour A; Morgun AV; Boitsova EB; Malinovskaya NA; Martynova GP; Khilazheva ED; Kopylevich NV; Gertsog GE; Salmina AB
    Front Cell Infect Microbiol; 2017; 7():276. PubMed ID: 28676848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An overview of the neuroprotective potential of rosmarinic acid and its association with nanotechnology-based delivery systems: A novel approach to treating neurodegenerative disorders.
    Fachel FNS; Schuh RS; Veras KS; Bassani VL; Koester LS; Henriques AT; Braganhol E; Teixeira HF
    Neurochem Int; 2019 Jan; 122():47-58. PubMed ID: 30439384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroimmune regulation of microglial activity involved in neuroinflammation and neurodegenerative diseases.
    González H; Elgueta D; Montoya A; Pacheco R
    J Neuroimmunol; 2014 Sep; 274(1-2):1-13. PubMed ID: 25091432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Role of Natural Compounds and their Nanocarriers in the Treatment of CNS Inflammation.
    Khadka B; Lee JY; Park DH; Kim KT; Bae JS
    Biomolecules; 2020 Oct; 10(10):. PubMed ID: 33019651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroprotection from complement-mediated inflammatory damage.
    Kulkarni AP; Kellaway LA; Lahiri DK; Kotwal GJ
    Ann N Y Acad Sci; 2004 Dec; 1035():147-64. PubMed ID: 15681806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastrointestinal immune system and brain dialogue implicated in neuroinflammatory and neurodegenerative diseases.
    Deretzi G; Kountouras J; Polyzos SA; Zavos C; Giartza-Taxidou E; Gavalas E; Tsiptsios I
    Curr Mol Med; 2011 Nov; 11(8):696-707. PubMed ID: 21902649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting nanoparticles across the blood-brain barrier with monoclonal antibodies.
    Loureiro JA; Gomes B; Coelho MA; do Carmo Pereira M; Rocha S
    Nanomedicine (Lond); 2014 Apr; 9(5):709-22. PubMed ID: 24827845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glia proinflammatory cytokine upregulation as a therapeutic target for neurodegenerative diseases: function-based and target-based discovery approaches.
    Van Eldik LJ; Thompson WL; Ralay Ranaivo H; Behanna HA; Martin Watterson D
    Int Rev Neurobiol; 2007; 82():277-96. PubMed ID: 17678967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene-BIT Life Sciences' third annual world congress. Anti-neurodegenerative and anti-inflammation biotherapeutics.
    Filep JG
    IDrugs; 2010 Feb; 13(2):73-5. PubMed ID: 20127554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mast cell-glia axis in neuroinflammation and therapeutic potential of the anandamide congener palmitoylethanolamide.
    Skaper SD; Facci L
    Philos Trans R Soc Lond B Biol Sci; 2012 Dec; 367(1607):3312-25. PubMed ID: 23108549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.